Reported Earnings • Mar 02
First quarter 2026 earnings released: CA$0.001 loss per share (vs CA$0.005 loss in 1Q 2025) First quarter 2026 results: CA$0.001 loss per share (improved from CA$0.005 loss in 1Q 2025). Revenue: CA$4.1k (down 94% from 1Q 2025). Net loss: CA$113.9k (loss narrowed 74% from 1Q 2025). New Risk • Mar 02
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$767k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$767k free cash flow). Shares are highly illiquid. Negative equity (-CA$1.3m). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (CA$7.3k revenue, or US$5.3k). Market cap is less than US$10m (CA$1.68m market cap, or US$1.23m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Board Change • Feb 19
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO & Director Candace Ryan was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Feb 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$1.5m). Revenue has declined by 71% over the past year. Revenue is less than US$1m (CA$3.4k revenue, or US$2.5k). Market cap is less than US$10m (CA$1.68m market cap, or US$1.23m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Reported Earnings • Feb 01
Full year 2025 earnings released: CA$0.012 loss per share (vs CA$0.09 loss in FY 2024) Full year 2025 results: CA$0.012 loss per share (improved from CA$0.09 loss in FY 2024). Revenue: CA$3.4k (down 99% from FY 2024). Net loss: CA$1.13m (loss narrowed 83% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 55% per year, which means it is performing significantly worse than earnings. Announcement • Jan 30
Hempalta Corp., Annual General Meeting, Apr 09, 2026 Hempalta Corp., Annual General Meeting, Apr 09, 2026. New Risk • Jan 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Revenue has declined by 34% over the past year. Revenue is less than US$1m (CA$350k revenue, or US$253k). Market cap is less than US$10m (CA$1.68m market cap, or US$1.22m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Announcement • Jan 03
Hempalta Corp Announces Appointment of Chris Ostafie and Anshu Khanna to Board of Directors, Effective December 23, 2025 Hempalta Corp. announced the appointment of Chris Ostafie and Anshu Khanna to its Board of Directors effective December 23, 2025. Chris Ostafie is a seasoned executive with extensive experience in retail operations and franchised business models. He has held senior leadership roles within multi-unit retail organizations, with expertise spanning operations management, network scaling, and performance optimization. Mr. Ostafie brings a strong operational perspective and governance discipline to the Board. Anshu Khanna is the President and Chief Executive Officer of WATCH IT!. She brings significant experience in retail leadership, brand management, and operations. Ms. Khanna holds a Post-Graduate Diploma in Sport and Event Marketing from George Brown College and a bachelors degree in economics and sociology from the University of Toronto. Recent Insider Transactions Derivative • Dec 27
President exercised options to buy CA$75k worth of stock. On the 23rd of December, Darren Bondar exercised options to buy 5m shares at a strike price of around CA$0.02, costing a total of CA$100k. This transaction amounted to 35% of their direct individual holding at the time of the trade. Since December 2024, Darren's direct individual holding has increased from 13.99m shares to 19.41m. Company insiders have collectively bought CA$96k more than they sold, via options and on-market transactions, in the last 12 months. Announcement • Nov 19
Hempalta Corp. announced that it expects to receive CAD 2 million in funding Hempalta Corp. announced a non-brokered private placement to issue 100,000,000 units at an issue price of CAD 0.02 for gross proceeds of CAD 2,000,000 on November 19, 2025. Each unit will consist of one common share and one-half common share purchase warrant, with each full warrant exercisable at CAD 0.05 for 24 months from closing. All securities will be subject to a four-month hold period in accordance with applicable securities laws. Completion of the private placement remains subject to final acceptance by the TSX Venture Exchange. Reported Earnings • Aug 31
Third quarter 2025 earnings released: CA$0.011 loss per share (vs CA$0.009 loss in 3Q 2024) Third quarter 2025 results: CA$0.011 loss per share (further deteriorated from CA$0.009 loss in 3Q 2024). Revenue: CA$53.3k (down 71% from 3Q 2024). Net loss: CA$1.06m (loss widened 37% from 3Q 2024). Board Change • Aug 22
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Mar 04
First quarter 2025 earnings released: CA$0.005 loss per share (vs CA$0.01 loss in 1Q 2024) First quarter 2025 results: CA$0.005 loss per share (improved from CA$0.01 loss in 1Q 2024). Revenue: CA$70.5k (down 41% from 1Q 2024). Net loss: CA$432.3k (loss narrowed 13% from 1Q 2024). Announcement • Jan 23
Hempalta Corp. announced that it expects to receive CAD 1.5 million in funding Hempalta Corp. announced a non-brokered private placement to issue 30,000,000 units at issue price of CAD 0.05 per unit for gross proceeds of CAD 1,500,000 on January 21, 2025. Each Unit will consist of one common share and one-half of one common share purchase warrant, with each full warrant being exercisable to purchase one Common Share at a price of CAD 0.10 for two years from the date of issuance. The Company may pay finders' fees to eligible finders, in accordance with applicable securities laws and the policies of the TSX Venture Exchange. The Private Placement is subject to approval of the TSXV, and all securities issued under the Private Placement will be subject to statutory hold periods expiring four months and one day from the date of issuance. Reported Earnings • Dec 19
Full year 2024 earnings released: CA$0.09 loss per share (vs CA$0.04 loss in FY 2023) Full year 2024 results: CA$0.09 loss per share (further deteriorated from CA$0.04 loss in FY 2023). Revenue: CA$539.7k (up 24% from FY 2023). Net loss: CA$6.44m (loss widened 250% from FY 2023). Announcement • Dec 11
Hempalta Corp. (TSXV:HEMP) acquired remaining 49.9% minority stake in Hemp Carbon Standard Inc. Hempalta Corp. (TSXV:HEMP) acquired remaining 49.9% minority stake in Hemp Carbon Standard Inc. on December 10, 2024. The transaction includes the acquisition of 20,399,999 Class A common voting shares of HCS held by Climafi Ltd. ("Climafi") (the "Acquisition") for the following aggregate consideration: (i) a C$90,000 cash payment to Climafi on the closing date (the "Closing Cash Payment"); (ii) subject to certain terms and conditions, a potential earnout of C$75,000 in the event that HCS sells the remaining 2023 carbon credits prior to September 30, 2025 for aggregate consideration to HCS of not less than US$359,050
(the "First Earnout"); and (iii) subject to certain terms and conditions, a potential earnout of C$335,000 in the event that HCS sells its 2024 carbon credits prior to September 30, 2025 for aggregate consideration to HCS of not less than US$1,250,000.
Hempalta Corp. (TSXV:HEMP) completed the remaining 49.9% minority stake in Hemp Carbon Standard Inc. on December 10, 2024. Reported Earnings • Aug 23
Third quarter 2024 earnings released Third quarter 2024 results: CA$0.009 loss per share. Net loss: CA$772.5k (flat on 3Q 2023). New Risk • Aug 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 23% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (23% average weekly change). Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (CA$488k revenue, or US$356k). Market cap is less than US$10m (CA$11.4m market cap, or US$8.29m). Minor Risk Less than 3 years of financial data is available. New Risk • Jul 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$13.3m (US$9.65m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (CA$488k revenue, or US$355k). Market cap is less than US$10m (CA$13.3m market cap, or US$9.65m). Minor Risk Less than 3 years of financial data is available. Reported Earnings • May 30
Second quarter 2024 earnings released Second quarter 2024 results: CA$0.01 loss per share. Net loss: CA$512.5k (flat on 2Q 2023). Reported Earnings • Apr 01
First quarter 2024 earnings released First quarter 2024 results: CA$0.01 loss per share. Net loss: CA$496.9k (flat on 1Q 2023). Board Change • Mar 26
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 